Equities

Gold River Productions Inc

GRPS:PKC

Gold River Productions Inc

Actions
  • Price (USD)0.0032
  • Today's Change0.00 / 0.00%
  • Shares traded294.00k
  • 1 Year change-22.86%
  • Beta-0.8182
Data delayed at least 15 minutes, as of May 02 2024 20:40 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Gold River Productions, Inc. is a product-based company offering alternatives to toxic pharmaceuticals. The Company’s products are developed for discomfort, sleep, anxiety, energy, and other concerns. The Company’s products include Painplex, Sleepy Watermelon Gummies, Relief Raspberry Discomfort Relief Gummies, Calming Mango Gummies, Energyplex, Inflammaplex and Longevityplex. Its Painplex product delivers relief by acting on different pathways than the Cannabinoid (CB)1 and CB2 receptors addressed by its Relief Gummy.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2005
  • Employees1.00k
  • Location
    Gold River Productions Inc48 S Chestnut StVENTURA 93001United StatesUSA
  • Phone+1 (877) 229-9792
  • Websitehttps://www.grpsinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SYBLEU Inc11.70k-307.88k4.30m--------367.87-0.0293-0.02930.0011-0.03670.0641-------168.63-----------2,631.45-----8.484.96--0.00--26.51------
Bio Path Holdings Inc0.00-16.08m4.32m10.00--3.87-----35.76-35.760.000.71360.00----0.00-167.56-70.80-206.12-76.87------------0.00-------15.94------
China Pharma Holdings Inc7.01m-3.08m4.34m231.00--0.4171--0.6184-1.06-1.062.070.70160.40942.1815.1430,351.95-17.98-29.66-41.91-55.25-4.016.47-43.91-73.090.332-8.420.3121---13.48-10.6822.50---25.78--
Mosaic Immunoengineering Inc0.00-1.01m4.35m3.00---------0.1397-0.13970.00-0.81070.00----0.00-457.45-----------------35.84--------57.65------
Neximmune Inc0.00-32.34m4.36m6.00--0.9661-----30.86-30.860.003.290.00----0.00-125.24-115.07-178.52-165.07------------0.00------48.25---44.65--
GT Biopharma Inc0.00-7.60m4.38m2.00--0.5855-----5.57-5.570.005.410.00----0.00-49.26-205.36-78.83--------------0.00------63.62------
Exicure Inc23.79m3.07m4.41m7.000.3990.45451.070.18541.281.283.861.120.8729----1,830,000.0011.25-41.7518.34-55.57----12.88-302.07----0.00--6,068.1224.2995.97---59.57--
Marijuana Company Of America Inc1.50m-13.01m4.42m7.00------2.95-0.0071-0.00710.0003-0.00360.31375.617.64214,085.70-272.25-837.07----28.3739.75-867.96-3,809.920.031-0.6498----267.09159.6516.09------
Tharimmune Inc0.00-9.32m4.42m2.00--0.4821-----13.09-13.090.000.77780.00----0.00-105.69---127.01--------------0.00-------9.98------
Marizyme Inc590.91k-79.15m4.43m13.00------7.50-1.83-1.830.0139-0.47040.01170.957512.1345,454.62-157.28-29.47-314.26-30.4271.6367.78-13,393.85-8,518.470.025-0.5887----11.0418.20-247.03------
Gold River Productions Inc.-100.00bn-100.00bn4.45m1.00k--6.86----------0.0005----------------------------0.00-------100.11------
Manuka Inc671.00k-1.14m4.48m4.00------6.68-0.0128-0.01280.0066-0.01242.410.941237.28167,750.00-410.43-463.75----88.08---170.04-732.150.0194-----------854.23------
Petros Pharmaceuticals Inc5.82m-13.81m4.52m21.00--0.1628--0.7759-6.35-6.352.744.170.17590.95242.69277,256.70-24.66-32.43-33.75-68.0571.9862.04-140.20-201.701.74--0.391---2.83-16.1531.06------
Portage Biotech Inc0.00-144.90m4.55m7.00--0.1422-----7.96-7.960.001.620.00----0.00-111.60-19.70-113.27-26.48------------0.0087-------520.10------
Oragenics Inc37.65k-20.66m4.57m5.00--1.99--121.39-8.69-8.690.01671.030.0038----7,530.00-209.44-97.60-252.98-106.24-----54,862.55-36,169.75----0.0898---71.37---44.56--51.64--
Target Group Inc3.72m-323.67k4.69m49.00----9.611.26-0.0008-0.00080.0058-0.01130.45353.407.2075,921.84-3.95-37.99---78.7644.49---8.70-586.970.1288-0.46642.57----577.8392.84---58.54--
Data as of May 02 2024. Currency figures normalised to Gold River Productions Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.